应用Amplatzer封堵器治疗动脉导管未闭的疗效评价

目的评价Amplatzer封堵器经导管治疗动脉导管未闭的疗效.方法经7F导管置入Amplatzer封堵器,术后行侧位降主动脉造影、超声心动图检查有无残余分流.结果6例全部一次封堵成功,无任何并发症发生.术后10 min行侧位降主动脉造影示2例有少量残余分流.术后1 d行超声心动图检查无残余分流,随访3～22个月无再通或残余分流.结论应用Amplatzer封堵器经导管治疗动脉导管未闭是一种安全有效的介入方法,操作简便,成功率高,疗效可靠.     

应用Amplatzer封堵器治疗动脉导管未闭的疗效评价

目的 评价Amplatzer封堵器经导管治疗动脉导管未闭的疗效。方法 经7F导管置入Amplatzer封堵器，术后行侧位降主动脉造影、超声心动图检查有无残余分流。结果 6例全部一次封堵成功，无任何并发症发生。术后10min行侧位降主动脉造影示2例有少量残余分流。术后1d行超声心动图检查无残余分流，随访3～22个月无再通或残余分流。结论 应用Amplatzer封堵器经导管治疗动脉导管未闭是一种安全有效的介入方法，操作简便，成功率高，疗效可靠。     

应用Amplazter封堵器治疗动脉导管未闭(PDA)的疗效评价

目的　应用Amplazter封堵器经皮顺行导管治疗动脉导管未闭并对其疗效进行评价。方法　全组 1 8例 ,男 8例 ,女 1 0例 ,平均年龄 6 .78± 4 .65(2 .5～ 33)岁 ,平均体重 2 6 .2± 1 1 .9(1 2 .4～ 55)kg。动脉导管未闭最窄处直径为 4 .86± 1 .97(2 .0～ 1 0 .0 )mm。经 6或 7F导管置入Amplazter封堵器 ,术后 1 0min行侧位降主动脉造影观察有无分流。术后 1天、1个月、6个月行超声心动图检查观察有无残余分流及动脉导管未闭再通。结果　所有病例均一次封堵成功 ,无任何并发症发生。术后 1 0min降主动脉造影示 3例有微至少量残余分流。术后 2 4h超声心动图均无残余分流。随访 1～ 6个月 ,均未发现有残余分流及再通。结论　应用Amplazter封堵器治疗直径达 1 0mm的动脉导管未闭是一种安全有效的介入方法 ,操作简便 ,成功率高 ,疗效可靠。     

应用国产Amplatzer封堵器治疗动脉导管未闭26例疗效观察

目的评价国产Amplatzer封堵器经导管治疗动脉导管未闭即刻和近期疗效。方法全组经导管堵闭PDA26例，男9例，女17例，年龄（3—54）岁，体重（8～72）kg。均经超声心动图确诊。5F、6F或7F置入Amplatzer封堵器。术后10min行左侧位降主动脉造影，术后24～72h、1周、1个月、6个月行超声心动图检查观察封堵效果及有无并发症。结果全组技术成功率100％。术后即刻所有患者胸骨左缘第二肋间连续性杂音消失，10min后行左侧位降主动脉造影示24例完全堵闭（92．3％），2例存在极少量残余分流，但无溶血。且48h后超声心动图示该分流消失。动脉导管最狭窄处直径为2．9～12．0mm。术后l周、1个月、6个月行超声心动图检查无残余分流及动脉导管未闭再通。结论应用国产Amp1atzer封堵器治疗PDA是一种安全、微创的介入性治疗方法，近期疗效可靠，成功率高，操作简便，是目前治疗动脉导管未闭最理想的方法。     

应用Amplatzer封堵器治疗动脉导管未闭(摘要)

目的　评价Amplatzer封堵器 (深圳先健公司 )治疗动脉导管未闭 (Patentductusarteriosus,PDA)的初步疗效。方法　经导管置入Amplatzer封堵器治疗PDA共 7例 ,平均年龄为 2 0 .93± 15 .3 3 (3 .5～ 5 2 )岁。术中造影测PDA最窄处平均直径为 6.3 3± 3 .45 (2 .9～ 9.1)mm ,PDA均为漏斗型 ,经 7F～ 10F输送鞘管置入Amplatzer封堵器封闭PDA。术后 10min行左侧位降主动脉造影 ,术后 2 4～ 72小时行彩色多谱勒超声心动图检查 ,分别观察有无残余分流及有无PDA再通。结果　 7例封堵器均一次性放置成功 (10 0 % ) ,无并发症发生。术后 10min造影示分流完全消失6例 (85 .71% ) ,少量分流 1例 (14 .2 9% ) ,术后 2 4～ 72小时彩色多谱勒超声示原 1例少量分流者仍有微量分流 ,但无溶血。结论　应用Amplatzer封堵器 (国产 )治疗PDA是一种安全有效的介入性治疗方法 ,近期疗效可靠 ,成功率高 ,操作简便。     

Amplatzer封堵器治疗动脉导管未闭

目的　初步评价 Am platzer封堵器治疗动脉导管未闭的疗效、安全性 ;并探讨超声心动图在封堵治疗随访中的作用。　方法　选择动脉导管未闭 4 5例应用 Amplatzer封堵器经皮静脉导管封堵法治疗。以降主动脉造影及心脏超声测定 PDA最小内径 ,并应用心脏超声评价其疗效及术后心功能的变化。　结果　 4 5例手术全部成功 ,4 2例在封堵器到位后 30 min经主动脉造影证实完全堵闭 ;2例术中发现仍有少量分流 (1例术后 1 0 d复查心脏超声证实无残余分流 ,1例 2 0月后超声检查仍有少量残余分流 ) ;1例术后有较多残余分流 ,术后 4 h发生溶血 ,随后行外科手术治疗。X线造影、2 DE及 CDEI所测得 PDA的最小内径分别为 5 .5± 2 .0 ,6 .9± 2 .0及 5 .8± 3.2 mm。2 DE与 X线相关系数为 0 .86 ;CDEI与 X线相关系数为 0 .97。随访中未发现封堵器发生位置变化、占位效应、局部湍流现象及压力阶差。封堵术后 1 0月患者 PA、EDD、EDV、ESV均有下降 ,较术前差异有显著性。　结论　 Am-platzer封堵器治疗动脉导管未闭是一种安全有效、创伤小、成功率高、操作简单的介入治疗方法。超声心动图在适应证及封堵器的选择、术后疗效观察、血流动力学评价有较好的应用价值     

Amplatzer封堵器治疗动脉导管未闭效果评价

目的 :评价 Amplatzer封堵器治疗动脉导管未闭 ( PDA)的疗效。方法 :6例患者经静脉使用 6 F输送鞘管置入 Amplatzer封堵器。术后 2 4 h和 6个月行超声心动图检查。结果 :PDA平均最小直径为 4 .4± 1.6 mm( 3～8m m) ,6例封堵均获成功。造影示无残余分流 5例 ,微量残余分流 1例 ,2 4 h超声心动图检查残余分流消失。无并发症发生。结论 :应用 Am platzer封堵器经导管封堵动脉导管未闭安全简便、疗效可靠 ,是治疗动脉导管未闭的理想方法     

Amplatzer封堵器治疗动脉导管未闭的临床观察

目的探讨Amplatzer封堵器治疗动脉导管未闭 (PDA)的疗效、安全性及可靠性。方法治疗 1 2例经临床、心电图、X线和心脏彩色多普勒超声检查确诊的PDA患者 ,年龄 2～ 1 7( 6 .2± 3)岁 ,体重 8～ 6 2 .5( 2 3.1± 2 .3)kg。其中2例经外科行“动脉导管结扎术”后再通患者。采用美国AGA公司生产的Amplatzer自膨性蘑菇状封堵器 ,选择封堵器的型号较PDA最窄径大 2mm ,用 6F传送鞘经静脉置入 ,术后即刻行胸主动脉造影。手术前、后均行血液动力学监测 ,术后 2 4h、3个月、6个月、1 2个月行心脏彩色多普勒超声及X线检查。结果PDA最窄径 1 .8～ 6 .3( 3.7± 1 .4 )mm ,手术成功率 1 0 0 % ,术后即刻听诊杂音消失者 1 1例 ,轻度收缩期杂音者 1例。 1 5min后胸主动脉造影显示 1 1例完全闭塞( 91 .6 % ) ,仅 1例有极少量残余分流 ,术后 72h彩色多普勒超声复查分流消失。全组患者无任何导管及临床并发症发生 ,随访 3～ 1 2 ( 7.3± 2 .7)个月 ,所有患者无PDA再通及封堵器移位。结论Amplatzer封堵器操作简便 ,安全有效 ,成功率高 ,适用于各种类型PDA ,患者也容易接受 ,是目前介入治疗PDA最理想的方法。在临床上具有广泛应用前景     

应用Amplatzer封堵器治疗儿童房间隔缺损和动脉导管未闭疗效观察

目的 对应用Amplatzer封堵器治疗继发孔型房间隔缺损和动脉导管未闭的疗效进行初步评价。方法 房间隔缺损患儿4例,在透视及彩色二维超声心动图监视下经导管置入Amplatzer封堵器封堵房间隔缺损。动脉导管未闭患儿7例,在透视下经6F输送器置入Amplatzer封堵器,术后10分钟主动脉弓降部造影。所有病例均在术后48小时、1月、3月、6月、1年、2年分别行超声心动图检查评价疗效。结果 11例患儿中,除1例戽间隔缺损术后48小时超声心动图显示有残余分流外,其余均完全闭合,5例随访2年、3例随访6个月未见任何并发症。结论 应用Amplatzer封堵器经导管治疗房间隔缺损、动脉导管未闭是安全、有效的介入方法,近期疗效满意。     

经导管介入治疗小儿动脉导管未闭(附10例报告)

10例动脉导管未闭最窄处直径为1．2～4．4mm，均值为3．06mm。由股静脉途径置入Amplatzer封堵器，或由股动脉途径置入弹簧圈；术后10min行降主动脉左侧位造影观察有无分流。术后1d、1个月行超声心动图检查观察有无残余分流与再通。结果：10例均一次封堵成功，24h复查心脏彩超提示9例封堵完全，1例残余分流，1个月后复查分流消失。认为经导管介入治疗PDA是适用于小儿、安全有效、操作简便、值得推广的治疗方法。     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

Dr.Zhang Ren''''s Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

Luo Lingjie''''s Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

猪肺磷脂注射液联合经鼻持续气道正压通气对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性的影响

目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P＜0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P＜0.05),PaCO2均随观察时间的延长而降低(P＜0.05).观察组治疗有效率为87.5％,显著高于对照组的70.0％ (P ＜0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P＜0.05),且观察组明显低于对照组(P＜0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.     

Survey and practice of reporting quality of randomized controlled clinical trials on traditional Chinese medicine

Evidence obtained from randomized controlled trials （RCTs） has been generally accepted as the gold standard in the evaluation of clinical effectiveness. Readers need to understand the trial design, implementation, results, analysis and interpretation, so as to fully Jnderstand the results of RCTs. Thus, the investigators of RCTs have to report these items in a complete, accurate and clear manner. Since 1998, we have conducted several evaluations on the reporting quality of RCTs published in Chinese journals on traditional Chinese medicine （TCM） and results have shown that there is an urgent need for higher quality RCTs on TCM.     

TCM Treatment of Ankylosing Spondylitis by Tonifying the Kidney and Strengthening the Governor Vessel

Ankylosing spondylitis is a chronic and progressive disorder with inflammation mainly involving the central axis joints. It mainly affects the cervical spine and the lumbosacral area, with the pathogenesis closely related to the kidney and the Governor Vessel (GV). TCM holds that the syndrome is deficiency in origin and excess in superficiality, which is due to insufficiency of the kidney, deficiency of GV, and blocking of the channels with the invasion of exogenous evil, leading to poor circulation of qi and blood and malnutrition of the bones, muscles and joints. The TCM method of tonifying the kidney and strengthening GV to regulate circulation of qi and blood and check the arthralgia pain should be adopted, with the Kidney-Tonifying and GV Strengthening Decoction (益肾强督汤) prescribed.     

IMPROVING P-gp EXPRESSION IN HUMAN MONONUCLEAR CELLS IN VITRO TRANSFECTED BY MULTIDRUG RESISTANCE-1 mRNA

CHEMOTHERAPY playsa greatrolein the treat- ment of malignanttumors,especiallyingynecolo- gicalones.But inanticancerchemotherapy,leuko-cytopeniaisfrequentlytheprimarydose-limitingsideeffect factor.Moreover,cancersarefrequentlychemoresistantbe-causeof overexpressionof P-glycoprotein(P-gp), which isencodedby multidrugresistancegene (MDR1 ) and detectableinup to50% ofhuman cancersand renderscellsresistancetoanticancerdrugs.The safetyand potentialtherapeuticbenefitof mdr1 gene transferredto h…